SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 139 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,000 | +8.4% | 11,479 | +56.1% | 0.00% | – |
| Q2 2023 | $154,000 | +19.4% | 7,353 | +19.5% | 0.00% | – |
| Q1 2023 | $129,000 | -46.5% | 6,151 | -35.1% | 0.00% | – |
| Q4 2022 | $241,000 | +177.0% | 9,478 | +161.7% | 0.00% | – |
| Q3 2022 | $87,000 | +1350.0% | 3,622 | +1144.7% | 0.00% | – |
| Q2 2022 | $6,000 | -88.5% | 291 | -90.4% | 0.00% | – |
| Q1 2022 | $52,000 | -72.9% | 3,016 | -65.5% | 0.00% | – |
| Q4 2021 | $192,000 | +2033.3% | 8,731 | +1818.9% | 0.00% | – |
| Q3 2021 | $9,000 | -83.0% | 455 | -85.2% | 0.00% | – |
| Q2 2021 | $53,000 | -7.0% | 3,078 | +21.7% | 0.00% | – |
| Q1 2021 | $57,000 | +850.0% | 2,530 | +833.6% | 0.00% | – |
| Q4 2020 | $6,000 | +500.0% | 271 | +652.8% | 0.00% | – |
| Q3 2020 | $1,000 | -95.7% | 36 | -97.7% | 0.00% | – |
| Q2 2020 | $23,000 | +27.8% | 1,542 | -4.3% | 0.00% | – |
| Q1 2020 | $18,000 | +20.0% | 1,611 | -2.7% | 0.00% | – |
| Q4 2019 | $15,000 | +87.5% | 1,655 | +61.3% | 0.00% | – |
| Q3 2018 | $8,000 | -27.3% | 1,026 | -33.5% | 0.00% | – |
| Q2 2018 | $11,000 | -15.4% | 1,543 | +71.4% | 0.00% | – |
| Q1 2018 | $13,000 | – | 900 | +3003.4% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 29 | -96.5% | 0.00% | – |
| Q3 2017 | $10,000 | +900.0% | 833 | +2213.9% | 0.00% | – |
| Q2 2017 | $1,000 | -66.7% | 36 | -84.7% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 236 | -13.2% | 0.00% | – |
| Q4 2016 | $2,000 | – | 272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $24,631,000 | 16.36% |
| Kynam Capital Management, LP | 2,272,915 | $54,618,000 | 11.51% |
| Frazier Life Sciences Management, L.P. | 3,412,838 | $82,010,000 | 6.32% |
| Foresite Capital Management IV, LLC | 690,000 | $16,581,000 | 5.33% |
| Paradigm Biocapital Advisors LP | 1,085,142 | $26,076,000 | 3.48% |
| ACUTA CAPITAL PARTNERS, LLC | 324,614 | $7,800,000 | 3.36% |
| COMMODORE CAPITAL LP | 738,110 | $17,737,000 | 2.85% |
| SPHERA FUNDS MANAGEMENT LTD. | 822,696 | $19,769,000 | 2.74% |
| Avidity Partners Management LP | 5,586,900 | $134,253,000 | 2.73% |
| HealthCor Management, L.P. | 859,240 | $20,648,000 | 2.58% |